Across the ARK Genomic Revolution ETF and the ARK Innovation ETF, Wood bought $6.1 million in Recursion Pharmaceuticals, $1.2 million in Intellia Therapeutics, and $5.3 million in Veracyte.

Naarden-based venture capital firm Forbion, which specialises in life sciences companies, has raised €2.3 billion for 2 new ...

Dutch haul comes despite European drugmakers and investors warning the region is losing ground.

A three-day special programme on agricultural production and development began at the Guwahati Biotech Park in Amingaon on ...

A Scottish biotech firm has secured a £2.5m investment to support a new commercial-scale production facility in Grangemouth.

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated ...

Scottish biotech company MiAlgae has secured a £2.5 million investment from the Scottish National Investment Bank to support ...

Andrew Huberman, the Stanford neuroscientist, predicts that the world's most powerful AI labs will inevitably pivot to biotech, driven by a ...

India, Oct. 6 -- The global demand for Vitamin D3 is being supported by rising health awareness, increasing nutritional ...

An Edinburgh biotech company has received a £2.5 million funding boost from the Scottish National Investment Bank to support ...

Law360 is on it, so you are, too. A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are ...